When I began my career in the field of microbiology more than 50 years ago, the only tick-borne disease that drew serious concern was Rocky Mountain spotted fever. Today, that landscape has changed dramatically, with a growing list of tick-borne illnesses, led by Lyme disease, which now pose significant public health challenges.

The Centers for Disease Control and Prevention (CDC) has also identified an emerging condition known as alpha-gal syndrome (AGS). While not a disease in the traditional sense, it is a serious allergic reaction triggered by a bite from the Lone Star tick, which potentially leads to severe, and in some cases life-threatening, responses.

A growing number of Americans are discovering this unusual and often alarming allergy, one that can make a hamburger, a steak or even a slice of bacon a potential medical threat. AGS is a type of food allergy to a sugar molecule called galactose-α-1,3-galactose (alpha-gal), which is found in most mammals but not in humans, fish or poultry. 

Unlike typical food allergies that are triggered immediately after eating, AGS has a delayed reaction—symptoms can appear three to six hours after consuming red meat such as beef, pork or lamb.

This delay often makes the condition difficult to diagnose. People could wake up in the middle of the night with hives, abdominal pain or even life-threatening anaphylaxis, without immediately connecting the reaction to what they ate for dinner.

The condition begins with the bite of the Lone Star tick, commonly found in the southeastern and eastern United States, though its range has been expanding northward and westward. When this tick feeds on human blood, it can transfer alpha-gal into the bloodstream, prompting the immune system to produce antibodies against it.

Afterward, consuming red meat can trigger an allergic reaction because the body now recognizes alpha-gal as a threat.

Symptoms of AGS vary widely. Some people experience mild itching or hives, while others may develop severe reactions, including:

Swelling of the lips, face or throat; 

Gastrointestinal distress (nausea, vomiting, diarrhea);

Difficulty breathing; or

A dangerous drop in blood pressure.

In the most severe cases, AGS can lead to anaphylaxis, a medical emergency requiring immediate treatment with epinephrine.

Researchers and public health officials, including those at the Centers for Disease Control and Prevention, have noted a steady increase in reported cases of AGS over the past decade. This rise is believed to be linked to the expanding population and geographic spread of the Lone Star tick, influenced by climate change, wildlife patterns and suburban development.

Because symptoms are often delayed and mimic other conditions, experts suspect that many cases go undiagnosed.

Currently, there is no cure for alpha-gal syndrome. The primary treatment is strict avoidance of foods containing alpha-gal—primarily red meat and, in some cases, dairy products and gelatin. Patients are often advised to carry an epinephrine auto-injector in case of severe reactions.

Interestingly, some individuals may see their sensitivity decrease over time, especially if they avoid further tick bites. However, repeated bites can worsen or prolong the condition.

Prevention is key

Preventing tick bites is the first line of defense. Health experts recommend:

Using insect repellents containing DEET 

Wearing long sleeves and pants in wooded or grassy areas 

Performing thorough tick checks after outdoor activities 

Promptly removing any attached ticks 

Alpha-gal syndrome is a striking example of how environmental changes and human health intersect in unexpected ways. A single tick bite can fundamentally alter a person’s diet and lifestyle, turning once-enjoyed meals into potential hazards.

As awareness grows, both among physicians and the public, earlier diagnosis and better prevention may help limit the impact of this unusual and increasingly recognized condition.

Michael Kossove is professor emeritus and an adjunct professor of microbiology at Touro University’s School of Health Sciences. He is a polio researcher and the author of “Polio Post-Polio and the Survivors.” He can be reached at Professormike2@aol.com.